期刊文献+

儿童C1q肾病4例报告 被引量:7

Pediatric C1q nephropathy:four cases report and literature review
下载PDF
导出
摘要 目的提高对儿童C1q肾病的认识。方法回顾性分析4例确诊为C1q肾病患儿的临床、病理及预后特点。结果4例患儿临床表现及病理均符合C1q肾病诊断标准,其中2例临床表现为难治性肾病,1例为镜下血尿合并蛋白尿,1例为肾炎性肾病、高血压脑病及肾功能异常。光镜下2例呈轻至中度系膜增生性肾炎表现,1例为轻微病变,1例呈硬化性肾炎。免疫荧光下2例呈"满堂亮"表现。电镜下均未见明显电子致密物沉积。1例镜下血尿合并蛋白尿患儿加服泼尼松1年后痊愈;1例难治性肾病予足量泼尼松并加用CTX治疗4个月,临床仍无效。1例表现为肾炎性肾病及高血压脑病患儿予泼尼松、骁悉、洛汀新等治疗,随访17个月,肾功能逐步恶化,进展至慢性肾功能不全;另1例失访。随访末患儿自身抗体及血补体均正常。结论C1q肾病是一种较少见的肾小球疾病,临床及病理表现多样,治疗效果和长期预后与临床表现、病理改变密切相关。
出处 《临床儿科杂志》 CAS CSCD 北大核心 2010年第4期337-340,共4页 Journal of Clinical Pediatrics
关键词 C1Q肾病 病理 儿童 C1q nephropathy pathology children
  • 相关文献

参考文献8

  • 1Jennette JC, Hipp CG. Clq nephropathy: a distinct pathologicentity usually causing nephritic syndrome [J]. Am J Kidney Dis, 1985,6(2) : 103-110.
  • 2Vizjak A, Ferluga D, Rozic M, et al. Pathology, clinical presentations, and outcomes of Clq nephropathy [J].J Am Soc Nephro1,2008,19( 11 ) :2237-2244.
  • 3刘建华,何威逊,罗运九,朱光华,方明俊.八例C1q肾病的诊断与鉴别诊断[J].中华儿科杂志,2002,40(12):716-719. 被引量:5
  • 4Kersnik Levart T, Kenda RB, Avgustin Cavic M, et al. C1Q nephropathy in children [J]. Pediatr Nephrol,2005, 20(12) : 1756-1761.
  • 5Fukuma Y, Hisano S, Segawa Y, et al. Clinicopathologic correlation of Clq nephropathy in children [J]. Am J Kidney Dis, 2006, 47(3):412-418.
  • 6Sharman A, Furness P, Feehally J. Distinguishing Clq nephropathy from lupus nephritis [J]. Nephrol Dial Transplant, 2004,19 (6) : 1420-1426.
  • 7Weening JJ, D'agati VD, Schwartz MM, et ol. The classification of glomerulonephritis in systemic lupus erythematosus revisited [J]. Kidney Int,2004,65(2):521-530.
  • 8Lau KK, Gaber LW, Delos Santos NM, et al. Clq nephropathy: features at presentation and outcome [J ]. Pediatr Nephrol, 2005,20 (6) : 744-749.

二级参考文献1

共引文献4

同被引文献108

  • 1俞匀,朱大龙.脂联素及其受体研究进展[J].医学研究生学报,2005,18(9):841-844. 被引量:6
  • 2邢丽,解汝娟.H因子突变与非典型性溶血尿毒综合征[J].实用儿科临床杂志,2007,22(5):388-390. 被引量:1
  • 3薛新萍,曾文,杨林,李绍梅,李素敏,王彦.有毛细血管内增生的致密物沉积病一例[J].中华肾脏病杂志,2007,23(5):342-342. 被引量:2
  • 4Jiang L, Ding J, Tsai H, et al. Over-expressing TRPC6 podo- cytes induces cytoskeleton rearrangement through increases of intracellular Ca^2+ and RhoA activation [ J ]. Exp B iol Mcd (May- wood), 2011,236(2) : 184-193.
  • 5Rao J, Xu H, Sun L, et al. Expression of angiopoietin-like 3 as- sociated with puromycin-induced podocyte damage [J]. Neph- ron Exp Nephrol, 2010,115 (3) : e38-45.
  • 6Gao X, Xu H, Liu H, et al. Angiopoietin-like protein 3 regu- lates the motility and permeability of pedocytes by altering nephrin expression in vitro[J]. Biochem Biophys Res Commun, 2010,399(1) :31-36.
  • 7Yuzawa Y, Hasegawa M, Nabeshima K. Membranous nephropathy. Nippon Jinzo Gakkai Shi, 2010, 52: 894-898.
  • 8Lesher AM, Song WC. Review: complement and its regulatory proteins in kidney diseases. Nephrology (Carlton), 2010, 15: 663-675.
  • 9Sa~a JV, Ward PA. The complement system. Cell Tissue Res, 2011, 343:227-235.
  • 10Trouw LA, Seelen MA, Daha MR. Complement and renal disease. Mol Immunol, 2003, 40: 125-134.

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部